OPCH240920C37500
- 0.10
- 0.000.00%
Option Care Health Newsroom
Truist Financial Maintains Option Care Health(OPCH.US) With Buy Rating
Option Care Health Analyst Ratings
Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Raises Target Price to $40
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Qiagen (QGEN) and MiMedx Group (MDXG)
Option Care Health (OPCH) Gets a Buy From Truist Financial
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Teva Pharmaceutical (TEVA) and Option Care Health (OPCH)
JMP Securities Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $36
Goldman Sachs Maintains Option Care Health(OPCH.US) With Buy Rating, Announces Target Price $41
Option Care Health Earns 'Buy' Rating on Strong Financial Performance and Upbeat 2024 Outlook
Option Care Health Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Edwards Lifesciences (EW)
Barrington Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $38
Bank of America Securities Keeps Their Buy Rating on Option Care Health (OPCH)
Option Care Health Analyst Ratings
Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
Option Care Health (OPCH) Receives a Buy From Truist Financial
Truist Financial Sticks to Their Buy Rating for Option Care Health (OPCH)
Option Care Health Analyst Ratings
Deutsche Bank Adjusts Option Care Health Price Target to $36 From $35, Maintains Buy Rating